-
1
-
-
0025751563
-
Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischemic events
-
The SALT Collaborative Group. 10.1016/0140-6736(91)92233-R
-
The SALT Collaborative Group 1991 Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischemic events Lancet 338 1345 1349 10.1016/0140-6736(91)92233-R
-
(1991)
Lancet
, vol.338
, pp. 1345-1349
-
-
-
2
-
-
0028120906
-
Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
-
Antiplatelet Trialists Collaboration 1994 Collaborative overview of ramdomised trials of antiplatelet therapy-I: Prevention of death, myocardia1 infarction, and stroke by prolonged antiplatelet therapy in various categories of parents BMJ 308 81 106 (Pubitemid 24052591)
-
(1994)
British Medical Journal
, vol.308
, Issue.6921
, pp. 81-106
-
-
Altman, R.1
Carreras, L.2
Diaz, R.3
Figueroa, E.4
Paolasso, E.5
Parodi, J.C.6
Cade, J.F.7
Donnan, G.8
Eadie, M.J.9
Gavaghan, T.P.10
O'Sullivan, E.F.11
Parkin, D.12
Renny, J.T.G.13
Silagy, C.14
Vinazzer, H.15
Zekert, F.16
Adriaensen, H.17
Bertrand-Hardy, J.M.18
Bran, M.19
-
3
-
-
0037046655
-
Aspirin for primary prevention of coronary events
-
DOI 10.1056/NEJMcp012672
-
MS Lauer 2002 Clinical practice. Aspirin for primary prevention of coronary events N Engl J Med 346 1468 1474 10.1056/NEJMcp012672 12000818 (Pubitemid 34755716)
-
(2002)
New England Journal of Medicine
, vol.346
, Issue.19
, pp. 1468-1474
-
-
Lauer, M.S.1
-
4
-
-
0021280286
-
Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily). Effects on platelet aggregation and thromboxane formation
-
Lorenz Rl CV Schacky M Weber et al. 1984 Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily). Effects on platelet aggregation and thromboxane formation Lancet 1 1261 1264 (Pubitemid 14111081)
-
(1984)
Lancet
, vol.1
, Issue.8389
, pp. 1261-1264
-
-
Lorenz, R.L.1
Schacky, C.V.2
Weber, M.3
-
5
-
-
0023805341
-
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2
-
ISIS-2 Collaborative Group
-
ISIS-2 Collaborative Group 1988 Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2 Lancet 2 349 360
-
(1988)
Lancet
, vol.2
, pp. 349-360
-
-
-
6
-
-
0033065324
-
Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans
-
DOI 10.1016/S0016-5085(99)70545-7
-
B Cryer M Feldman 1999 Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans Gastroenterology 117 17 10.1016/S0016-5085(99)70545-7 1:CAS:528:DyaK1MXksFeltrg%3D 10381905 (Pubitemid 29297615)
-
(1999)
Gastroenterology
, vol.117
, Issue.1
, pp. 17-25
-
-
Cryer, B.1
Feldman, M.2
-
7
-
-
0034638656
-
Risk of gastrointestinal haemorrhage with long term use of aspirin: Metaanalysis
-
10.1136/bmj.321.7270.1183 1:CAS:528:DC%2BD3cXovVeltL8%3D 11073508
-
S Derry YK Loke 2000 Risk of gastrointestinal haemorrhage with long term use of aspirin: metaanalysis BMJ 321 1183 10.1136/bmj.321.7270.1183 1:CAS:528:DC%2BD3cXovVeltL8%3D 11073508
-
(2000)
BMJ
, vol.321
, pp. 1183
-
-
Derry, S.1
Loke, Y.K.2
-
8
-
-
33846803757
-
Low-dose aspirin and upper gastrointestinal damage: Epidemiology, prevention and treatment
-
DOI 10.1185/030079907X162656
-
A Lanas J Scheiman 2007 Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment Curr Med Res Opin 23 1 163 173 10.1185/030079907X162656 1:CAS:528:DC%2BD2sXos1CnsLY%3D 17257477 Review (Pubitemid 46201599)
-
(2007)
Current Medical Research and Opinion
, vol.23
, Issue.1
, pp. 163-173
-
-
Lanas, A.1
Scheiman, J.2
-
9
-
-
0036113540
-
Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin
-
DOI 10.1046/j.1365-2036.2002.01230.x
-
P Serrano A Lanas MT Arroyo et al. 2002 Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases Aliment Pharmacol Ther 16 1945 1953 10.1046/j.1365-2036. 2002.01355.x 1:CAS:528:DC%2BD38XptFSqur8%3D 12390104 (Pubitemid 34407526)
-
(2002)
Alimentary Pharmacology and Therapeutics
, vol.16
, Issue.4
, pp. 779-786
-
-
Lanas, A.1
Fuentes, J.2
Benito, R.3
Serrano, P.4
Bajador, E.5
Sainz, R.6
-
10
-
-
0033830067
-
Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin
-
1:CAS:528:DC%2BD3cXntFCmtr8%3D 11007221
-
HT Sorensen L Mellemkjaer WJ Blot et al. 2000 Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin Am J Gastroenterol 95 2218 2224 1:CAS:528:DC%2BD3cXntFCmtr8%3D 11007221
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 2218-2224
-
-
Sorensen, H.T.1
Mellemkjaer, L.2
Blot, W.J.3
-
11
-
-
20444417453
-
A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs
-
S Nakashima S Arai Y Mizuno et al. 2005 A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs Aliment Pharmacol Ther 21 Suppl 2 60 66 10.1111/j.1365-2036.2005.02476.x 1:CAS:528:DC%2BD2MXlvFShtbg%3D 15943849 (Pubitemid 40806583)
-
(2005)
Alimentary Pharmacology and Therapeutics, Supplement
, vol.21
, Issue.2
, pp. 60-66
-
-
Nakashima, S.1
Arai, S.2
Mizuno, Y.3
Yoshino, K.4
Ando, S.5
Nakamura, Y.6
Sugawara, K.7
Koike, M.8
Saito, E.9
Naito, M.10
Nakao, M.11
Ito, H.12
Hamaoka, K.13
Rai, F.14
Asakura, Y.15
Akamatu, M.16
Fujimori, K.17
Inao, M.18
Imai, Y.19
Ota, S.20
Fujiwara, K.21
Shiibashi, M.22
more..
-
12
-
-
27644558549
-
Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin
-
DOI 10.1111/j.1365-2036.2005.02649.x
-
ND Yeomans AI Lanas NJ Talley et al. 2005 Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin Aliment Pharmacol Ther 22 9 795 801 10.1111/j.1365-2036.2005.02649.x 1:STN:280:DC%2BD2MrkvFWruw%3D%3D 16225488 (Pubitemid 41564359)
-
(2005)
Alimentary Pharmacology and Therapeutics
, vol.22
, Issue.9
, pp. 795-801
-
-
Yeomans, N.D.1
Lanas, A.I.2
Talley, N.J.3
Thomson, A.B.R.4
Daneshjoo, R.5
Eriksson, B.6
Appelman-Eszczuk, S.7
Langstrom, G.8
Naesdal, J.9
Serrano, P.10
Singh, M.11
Skelly, M.M.12
Hawkey, C.J.13
-
13
-
-
0036829086
-
Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin?
-
G Holtmann J Gschossmann L Buenger et al. 2002 Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin? Gastroenterology 123 1451 1458 10.1053/gast.2002.36556 12404219 (Pubitemid 35231644)
-
(2002)
Gastroenterology
, vol.123
, Issue.5
, pp. 1451-1458
-
-
Holtmann, G.1
Gschossmann, J.2
Buenger, L.3
Gerken, G.4
Talley, N.J.5
|